- Home
- PBM vs EVOK Comparison
PBM vs EVOK Comparison
Compare PBM & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- EVOK
- Stock Information
- Founded
- PBM 1994
- EVOK 2007
- Country
- PBM Canada
- EVOK United States
- Employees
- PBM N/A
- EVOK N/A
- Industry
- PBM
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PBM
- EVOK Health Care
- Exchange
- PBM NYSE
- EVOK Nasdaq
- Market Cap
- PBM 7.5M
- EVOK 6.5M
- IPO Year
- PBM N/A
- EVOK 2013
- Fundamental
- Price
- PBM $1.79
- EVOK $4.40
- Analyst Decision
- PBM
- EVOK
- Analyst Count
- PBM 0
- EVOK 0
- Target Price
- PBM N/A
- EVOK N/A
- AVG Volume (30 Days)
- PBM 5.4M
- EVOK 30.8K
- Earning Date
- PBM 02-02-2025
- EVOK 03-13-2025
- Dividend Yield
- PBM N/A
- EVOK N/A
- EPS Growth
- PBM N/A
- EVOK N/A
- EPS
- PBM N/A
- EVOK N/A
- Revenue
- PBM N/A
- EVOK $8,617,036.00
- Revenue This Year
- PBM N/A
- EVOK $97.35
- Revenue Next Year
- PBM N/A
- EVOK $99.52
- P/E Ratio
- PBM N/A
- EVOK N/A
- Revenue Growth
- PBM N/A
- EVOK 100.35
- 52 Week Low
- PBM $1.51
- EVOK $3.54
- 52 Week High
- PBM $593.25
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- PBM 39.22
- EVOK 46.24
- Support Level
- PBM $1.61
- EVOK $4.07
- Resistance Level
- PBM $2.25
- EVOK $4.59
- Average True Range (ATR)
- PBM 0.22
- EVOK 0.28
- MACD
- PBM 0.06
- EVOK -0.02
- Stochastic Oscillator
- PBM 23.38
- EVOK 39.05
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.